Eiger BioPharmaceuticals Provides Update on Status of Planned Peginterferon Lambda COVID-19 Emergency Use Authorization Application
/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...
Sylvia Wheeler David Cory Bristol Myers Squibb Sarah Mathieson Prnewswire Eiger Biopharmaceuticals Inc European Medicines Agency
Source: prnewswire.com